|
Volumn 353, Issue 6304, 2016, Pages 1101-1102
|
Lentiviral vectors, two decades later
b
EPFL
(Switzerland)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;
LENTIVIRUS VECTOR;
BETA GALACTOSIDASE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CELLS AND CELL COMPONENTS;
GENE TRANSFER;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE RESPONSE;
VIRUS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CANCER GENE THERAPY;
CANCER IMMUNOTHERAPY;
DNA MODIFICATION;
GENE TRANSFER;
GENOTOXICITY;
HUMAN;
IMMUNOTOXICITY;
LONG TERMINAL REPEAT;
MACROPHAGE;
NONHUMAN;
PRIORITY JOURNAL;
PROMOTER REGION;
REVIEW;
STABLE EXPRESSION;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
ANIMAL;
BRAIN;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS;
MOLONEY MURINE LEUKEMIA VIRUS;
PROCEDURES;
RAT;
ANIMALS;
BETA-GALACTOSIDASE;
BRAIN;
GENE TRANSFER TECHNIQUES;
GENETIC THERAPY;
GENETIC VECTORS;
HIV;
HUMANS;
MOLONEY MURINE LEUKEMIA VIRUS;
RATS;
|
EID: 84987723796
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aah6192 Document Type: Review |
Times cited : (93)
|
References (22)
|